ADCT
ADC Therapeutics SA
NYSE · Healthcare · Biotechnology · CH
$1.44
+3.23%Leverage
- Debt / equity
- -1.83x
- Net debt / equity
- -0.87x
- Debt / assets
- 1.49x
- Debt / EBITDA
- -4.76x
- Net debt / EBITDA
- -2.26x
Liquidity & coverage
- Current ratio
- 3.03x
- Quick ratio
- 2.97x
- Cash ratio
- 2.54x
- Interest coverage
- -1.90x
- EBITDA / interest
- -1.68x
- Working capital
- $175.4M
Cash & dividend
- FCF / debt
- -0.25x
- Cash flow / debt
- -0.25x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026